Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $135M (100.0% shares, 0.0% debt)

Holdings (11)

NUVB Nuvation Bio 28.7%

Value $38.77M Shares 13,275,884 Est. Cost $11.18 Unrealized -72.7%

LXEO Lexeo Therapeutics 28.0%

Value $37.79M Shares 2,355,904 Est. Cost $12.69 Unrealized +14.4%

REPL Replimune Group 16.4%

Value $22.15M Shares 2,461,319 Est. Cost $17.40 Unrealized -59.9%

ENGN enGene Holdings Inc. 7.5%

Value $10.15M Shares 1,076,357 Est. Cost $10.40 Unrealized +23.4%

ALMS Alumis Inc 6.4%

Value $8.688M Shares 653,225 Est. Cost $13.30 Unrealized 0.0%

— Morphic Holding 4.0%

Value $5.446M Shares 159,846 Est. Cost $19.82 Unrealized —

SANA Sana Biotechnology, Inc. 3.4%

Value $4.607M Shares 843,750 Est. Cost $32.56 Unrealized -75.5%

— Ikena Oncology 2.7%

Value $3.711M Shares 2,249,123 Est. Cost $28.25 Unrealized —

IMUX Immunic Inc 1.5%

Value $1.985M Shares 1,788,160 Est. Cost $13.89 Unrealized -91.1%

SYRS Syros Pharmaceuticals 1.0%

Value $1.297M Shares 251,270 Est. Cost $8.12 Unrealized -35.3%

ENGNW enGene Holdings Inc. 0.3%

Value $383K Shares 321,502 Est. Cost $0.85 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	13,275,884	$38.77M	28.7%	$11.18	-72.7%	Common Stock Class A	67080N101
LXEO	Lexeo Therapeutics	2,355,904	$37.79M	28.0%	$12.69	+14.4%	Common Stock	52886X107
REPL	Replimune Group	2,461,319	$22.15M	16.4%	$17.40	-59.9%	Common Stock	76029N106
ENGN	enGene Holdings Inc.	1,076,357	$10.15M	7.5%	$10.40	+23.4%	Common Stock	29286M105
ALMS	Alumis Inc	653,225	$8.688M	6.4%	$13.30	0.0%	Common Stock	022307102
—	Morphic Holding	159,846	$5.446M	4.0%	$19.82	—	Common Stock	61775R105
SANA	Sana Biotechnology, Inc.	843,750	$4.607M	3.4%	$32.56	-75.5%	Common Stock	799566104
—	Ikena Oncology	2,249,123	$3.711M	2.7%	$28.25	—	Common Stock	45175G108
IMUX	Immunic Inc	1,788,160	$1.985M	1.5%	$13.89	-91.1%	Common Stock	4525EP101
SYRS	Syros Pharmaceuticals	251,270	$1.297M	1.0%	$8.12	-35.3%	Common Stock	87184Q206
ENGNW	enGene Holdings Inc.	321,502	$383K	0.3%	$0.85	—	Warrant	29286M113